Results 71 to 80 of about 27,895 (134)

Risk factors for infection with influenza A(H3N2) virus on a US university campus, October-November 2021. [PDF]

Influenza Other Respir Viruses, 2023
Lewis NM, Delahoy MJ, Sumner KM, Lauring AS, Bendall EE, Mortenson L, Edwards E, Stamper A, Flannery B, Martin ET.   +9 more
europepmc   +1 more source

INFLUENZA VIRUS EPIDEMIOLOGICAL SITUATION IN THE SOUTH OF WESTERN SIBERIA IN 2011-2012

Acta Biomedica Scientifica, 2012
In the result of the monitoring for influenza in the Novosibirsk region during the season 2011-2012 85 strains of influenza virus on the culture of MDCK cells were isolated: 79 strains A (H3N2) and 6 strains of influenza virus B (five strains belonged to
I. A. Sobolev, O. G. Kurskaya, E. V. Ivanova, A. G. Durymanov, T. N. Ilyicheva, V. N. Mickheyev, A. M. Shestopalov   +6 more
doaj  

Molecular Characterization of Influenza A/H3N2 Virus Isolated from Indonesian Hajj and Umrah Pilgrims 2013 to 2014. [PDF]

Life (Basel), 2023
Agustiningsih A, Indalao IL, Pangesti KA, Sukowati CHC, Ramadhany R.   +4 more
europepmc   +1 more source

Cats are more susceptible to the prevalent H3 subtype influenza viruses than dogs

Virulence
Recent reports have highlighted the increasing frequency of influenza A virus (IAV) spillover events from other species to dogs and cats. IAV, particularly the H3 subtype, exhibits a broad host range and a propensity for interspecies transmission, as ...
Jie Deng, Chunhui Ma, Junting Yu, Bo Chen, Shoujun Li, Pei Zhou   +5 more
doaj   +1 more source

Death in children with influenza A (H3N2) virus infection-associated encephalopathy: two case reports. [PDF]

J Int Med Res, 2023
Li SG, Liang H, Chen YW, Pang YS.
europepmc   +1 more source

A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023. [PDF]

Euro Surveill, 2023
Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Matsuura Y, Yamamoto S, Chiba S, Inoue Y, Minami I, Yoshikawa S, Yamazaki S, Kishida N, Nakamura K, Shirakura M, Watanabe S, Hasegawa H.   +16 more
europepmc   +1 more source

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir. [PDF]

Pharmaceuticals (Basel), 2023
Alchikh M, Obermeier PE, Schweiger B, Rath BA.   +3 more
europepmc   +1 more source

SARS-CoV-2/influenza A (H3N2) virus coinfection: epidemiological surveillance in Northeast Brazil. [PDF]

Rev Soc Bras Med Trop, 2022
Santos CAD, Bezerra GVB, Marinho ARRAA, Sena LOC, Menezes VJ, Teixeira DCP, Souza MF, Góes MAO, Martins-Filho PR.   +8 more
europepmc   +1 more source

MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to Embryonated Eggs. [PDF]

Vaccines (Basel), 2022
Chen H, Wang J, Liu Y, Ling IQE, Shih CC, Wu D, Fu Z, Lee RTC, Xu M, Chow VT, Maurer-Stroh S, Zhou D, Liu J, Zhai W.   +13 more
europepmc   +1 more source

A changing trend in diagnostic methods of Influenza A (H3N2) virus in human: a review. [PDF]

3 Biotech, 2021
Ravina, Manjeet, Mohan H, Narang J, Pundir S, Pundir CS.   +5 more
europepmc   +1 more source